STATE STREET CORP

Holdings History for Candel Therapeutics, Inc. - Common Stock (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$4,476,032	792,218	+103,452	+15%	$5.65	Q4 2025
30 Sep 2025	0%	+0%	$3,512,707	688,766	+36,787	+5.6%	$5.10	Q3 2025
30 Jun 2025	0%	+0%	$3,299,014	651,979	+88,575	+16%	$5.06	Q2 2025
31 Mar 2025	0%	+0%	$3,183,233	563,404	+2,435		$5.65	Q1 2025
31 Dec 2024	0%	+0%	$4,869,211	560,969	+68,964	+14%	$8.68	Q4 2024
30 Sep 2024	0%	+0%	$3,409,595	492,005	+19,207	+4.1%	$6.93	Q3 2024
30 Jun 2024	0%	+0%	$2,931,348	472,798	+445,198	+1613%	$6.20	Q2 2024
31 Mar 2024	0%	0%	$43,608	27,600	0		$1.58	Q1 2024
31 Dec 2023	0%	0%	$40,572	27,600	0		$1.47	Q4 2023
30 Sep 2023	0%	0%	$25,668	27,600	0		$0.93	Q3 2023
30 Jun 2023	0%	0%	$34,776	27,600	0		$1.26	Q2 2023
31 Mar 2023	0%	0%	$37,812	27,600	0		$1.37	Q1 2023
31 Dec 2022	0%	0%	$49,404	27,600	0		$1.79	Q4 2022
30 Sep 2022	0%	0%	$87,000	27,600	0		$3.15	Q3 2022
30 Jun 2022	0%	0%	$89,000	27,600	0		$3.22	Q2 2022
31 Mar 2022	0%	0%	$140,000	27,600	+1,000	+3.8%	$5.07	Q1 2022
31 Dec 2021	0%	0%	$208,000	26,600	0		$7.82	Q4 2021
30 Sep 2021	0%	+0%	$288,000	26,600	+26,600	NEW	$10.83	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.